Broadening access to cladribine should help more patients avoid hospital and free up clinic time.
“Broadening access to cladribine means thousands more patients will benefit from managing their treatment at home rather than regularly attending hospital appointments – as well giving women with MS ...
In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
Thousands of NHS patients to benefit from ‘take at home’ multiple sclerosis tablet in European first
Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...
A new study suggests that a simple treatment algorithm could significantly reduce disparities in multiple sclerosis care ...
The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback